These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


197 related items for PubMed ID: 10611554

  • 1. The comparison of the effects of fluticasone propionate and budesonide on clinical indices and on bone mineral density in the asthmatic patients: a one year treatment study.
    Harmanci E, Ak I, Ozdemir N, Vardareli E, Elbek O, Uçgun I.
    Allergol Immunopathol (Madr); 1999; 27(6):298-303. PubMed ID: 10611554
    [Abstract] [Full Text] [Related]

  • 2. Safety and efficacy of fluticasone and beclomethasone in moderate to severe asthma. Belgian Multicenter Study Group.
    Pauwels RA, Yernault JC, Demedts MG, Geusens P.
    Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):827-32. PubMed ID: 9517598
    [Abstract] [Full Text] [Related]

  • 3. A comparison of the relative growth velocities with budesonide and fluticasone propionate in children with asthma.
    Ferguson AC, Van Bever HP, Teper AM, Lasytsya O, Goldfrad CH, Whitehead PJ.
    Respir Med; 2007 Jan; 101(1):118-29. PubMed ID: 16735113
    [Abstract] [Full Text] [Related]

  • 4. [Evaluation of the clinical efficacy and the safety of salmeterol/fluticasone propionate accuhaler compared to budesonide turbuhalar in the control of adult asthma].
    Zhong NS, Zheng JP, Cai BQ, Xie CM, Sun TY, Wang DQ, Lin YP, Chen BY, Tao JJ, Kang J, Li Q, Xu YP, Zhou X, Guo XJ, Chen XD, Yin KS, Zhang DP, Zhou JY, Shen HH, Qiu C, Feng YL, Xiao BR.
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Apr; 28(4):233-7. PubMed ID: 15854431
    [Abstract] [Full Text] [Related]

  • 5. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
    Cowie RL, Boulet LP, Keith PK, Scott-Wilson CA, House KW, Dorinsky PM.
    Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
    [Abstract] [Full Text] [Related]

  • 6. [The long term effect of small dose budesonide turbuhaler on mild bronchial asthma].
    Weng JL, Zheng YS, Ma QF.
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):88-92. PubMed ID: 15854388
    [Abstract] [Full Text] [Related]

  • 7. Beclomethasone dipropionate versus budesonide inhalation suspension in children with mild to moderate persistent asthma.
    Terzano C, Allegra L, Barkai L, Cremonesi G.
    Eur Rev Med Pharmacol Sci; 2001 Feb; 5(1):17-24. PubMed ID: 11860218
    [Abstract] [Full Text] [Related]

  • 8. Potency ratio fluticasone propionate (Flixotide Diskus)/budesonide (Pulmicort Turbuhaler).
    Ställberg B, Pilman E, Skoogh BE, Hermansson BA.
    Respir Med; 2007 Mar; 101(3):610-5. PubMed ID: 16889952
    [Abstract] [Full Text] [Related]

  • 9. Adrenocortical activity with repeated administration of one-daily inhaled fluticasone propionate and budesonide in asthmatic adults.
    Wilson AM, Clark DJ, Devlin MM, McFarlane LC, Lipworth BJ.
    Eur J Clin Pharmacol; 1998 Jan; 53(5):317-20. PubMed ID: 9516029
    [Abstract] [Full Text] [Related]

  • 10. Effects of nebulized corticosteroids therapy on hypothalamic-pituitary-adrenal axis in young children with recurrent or persistent wheeze.
    Cetinkaya F, Kayiran P, Memioglu N, Tarim OF, Eren N, Erdem E.
    Pediatr Allergy Immunol; 2008 Dec; 19(8):773-6. PubMed ID: 18221460
    [Abstract] [Full Text] [Related]

  • 11. Fluticasone propionate and budesonide do not influence bone metabolism in the long term treatment of asthma.
    Harmanci E, Colak O, Metintas M, Alatas O, Yurdasiper A.
    Allergol Immunopathol (Madr); 2001 Dec; 29(1):22-7. PubMed ID: 11449531
    [Abstract] [Full Text] [Related]

  • 12. Systemic effects of inhaled fluticasone propionate and budesonide in adult patients with asthma.
    Derom E, Van Schoor J, Verhaeghe W, Vincken W, Pauwels R.
    Am J Respir Crit Care Med; 1999 Jul; 160(1):157-61. PubMed ID: 10390394
    [Abstract] [Full Text] [Related]

  • 13. Does measuring BHR add to guideline derived clinical measures in determining treatment for patients with persistent asthma?
    Koenig SM, Murray JJ, Wolfe J, Andersen L, Yancey S, Prillaman B, Stauffer J, Dorinsky P.
    Respir Med; 2008 May; 102(5):665-73. PubMed ID: 18328683
    [Abstract] [Full Text] [Related]

  • 14. Comparable effects of inhaled fluticasone propionate and budesonide on the HPA-axis in adult asthmatic patients.
    Ringdal N, Lundbäck B, Alton M, Rak S, Eivindson A, Bratten G, Kjaersgaard P.
    Respir Med; 2000 May; 94(5):482-9. PubMed ID: 10868712
    [Abstract] [Full Text] [Related]

  • 15. Adrenal suppression, evaluated by a low dose adrenocorticotropin test, and growth in asthmatic children treated with inhaled steroids.
    Kannisto S, Korppi M, Remes K, Voutilainen R.
    J Clin Endocrinol Metab; 2000 Feb; 85(2):652-7. PubMed ID: 10690871
    [Abstract] [Full Text] [Related]

  • 16. [An evaluation of the acceptance of budesonide turbuhaler by older Japanese patients with bronchial asthma when changed from fluticasone propionate (FP) or beclomethasone dipropionate (BDP)].
    Ohbayashi H, Yamase H.
    Arerugi; 2003 Jan; 52(1):31-8. PubMed ID: 12598720
    [Abstract] [Full Text] [Related]

  • 17. EXCEL: A randomised trial comparing salmeterol/fluticasone propionate and formoterol/budesonide combinations in adults with persistent asthma.
    Dahl R, Chuchalin A, Gor D, Yoxall S, Sharma R.
    Respir Med; 2006 Jul; 100(7):1152-62. PubMed ID: 16675212
    [Abstract] [Full Text] [Related]

  • 18. Therapeutic ratio of inhaled corticosteroids in adult asthma. A dose-range comparison between fluticasone propionate and budesonide, measuring their effect on bronchial hyperresponsiveness and adrenal cortex function.
    Nielsen LP, Dahl R.
    Am J Respir Crit Care Med; 2000 Dec; 162(6):2053-7. PubMed ID: 11112113
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics of epimeric budesonide and fluticasone propionate after repeat dose inhalation--intersubject variability in systemic absorption from the lung.
    Minto C, Li B, Tattam B, Brown K, Seale JP, Donnelly R.
    Br J Clin Pharmacol; 2000 Aug; 50(2):116-24. PubMed ID: 10930963
    [Abstract] [Full Text] [Related]

  • 20. Initial treatment of symptomatic mild to moderate bronchial asthma with the salmeterol/fluticasone propionate (50/250 microg) combination product (SAS 40023).
    Baumgarten C, Geldszus R, Behre U, Peslis N, Trautmann M, Viani-Initial Study Group.
    Eur J Med Res; 2002 Jan 29; 7(1):1-7. PubMed ID: 11827834
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.